Method for determining concentration of 5'-methoxyl-3',4'-methylenedioxyphenyl cinnamic acid isobutyl amide in plasma

A technology of cinnamic acid isobutylamide and methylenedioxyphenyl, which is applied in the field of pharmaceutical analysis, can solve the problems of no literature reports on the determination method, and achieve the effect of simple pretreatment method, easy operation and high sensitivity

Inactive Publication Date: 2015-06-17
JIANGSU PROVINCIAL HOSPITAL OF TCM
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there is no literature report on the determination method of K6 in plasma after taking the extract of effective parts of betelwort in human body

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for determining concentration of 5'-methoxyl-3',4'-methylenedioxyphenyl cinnamic acid isobutyl amide in plasma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Example 1: Determination of K6 concentration in human plasma.

[0024] 1. Experimental materials and instruments

[0025] K6 reference substance: provided by Suzhou Yihua Biomedical Technology Co., Ltd., batch number: 20131121; tinidazole reference substance: provided by China Institute for the Control of Pharmaceutical and Biological Products, batch number: 100336-200402; test water: ultrapure water; methanol: chromatography Pure (Merck Company).

[0026] API4000LC / MS / MS coupled instrument (Applied Biosystems, USA), chromatographic workstation: Analyst 1.4.2; Mettler MT-5 electronic balance (Mettler, Switzerland); LEGEND MICRO17R refrigerated high-speed centrifuge (Thermo, USA) ); 80-2 centrifuge (Jiangsu Jintan Ronghua Instrument Manufacturing Co., Ltd.) Millipore Drict-Q5 ultrapure water machine (French Millipore Company). Centrifugal concentrator: Labconco CentriVap Console (Labconco, USA)

[0027] 2. Liquid conditions

[0028] 1. Liquid chromatography condition...

Embodiment 2

[0048] Embodiment 2: the mensuration of K6 concentration in human plasma

[0049] Referring to Example 1, 6 females took the extract of effective parts of betelwort (containing 20.8 mg of K6) on an empty stomach, and took it with 250 mL of warm boiled water; 4 mL of peripheral venous blood was collected 3 hours after administration, injected into a heparin tube, protected from light, and centrifuged (3000r·min -1 , 10 min) to prepare plasma. The treatment and determination conditions of the drug-containing plasma samples were the same, and the results showed that the K6 contents in the plasma of the 6 women who were given the extract of the effective part of the betelwort were 9.323, 12.54, 12.55, 13.09, 5.011, and 7.569 ng·mL -1 .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a met / hod for determining the concentration of 5'-methoxyl-3',4'-methylenedioxyphenyl cinnamic acid isobutyl amide in plasma. A liquid chromatography-mass system is adopted to determine. The method comprises the following steps: taking a to-be-determined sample first, adding a certain quantity of organic solvent for extraction, separating through a chromatographic column after pretreatment, and determining by using a mass spectrometry detector. The method disclosed by the invention has the advantages of rapidity, accuracy, high sensitivity, simplicity and convenience in operation and is suitable for determining the concentration of 5'-methoxyl-3',4'-methylenedioxyphenyl cinnamic acid isobutyl amide in plasma.

Description

technical field [0001] The invention belongs to the technical field of drug analysis, and relates to a method for analyzing and measuring drugs in vivo, in particular to a method for measuring the concentration of 5'-methoxy-3',4'-methylenedioxyphenylcinnamic acid isobutylamide in plasma. Background technique [0002] Piper Laetispicum (Piper Laetispicum C.DC.) is a plant belonging to the family Piperaceae. It is mainly produced in Hainan, Guangdong, Guangxi, Yunnan and other places. It is used for promoting blood circulation, reducing swelling and relieving pain. It is mainly used for bruises, blood stasis and swelling . Recent studies have found that betel has a strong antidepressant effect, and its activity is related to a series of amide compounds. Among them, 5'-methoxy-3',4'-methylenedioxyphenyl cinnamic acid isobutylamide (C15H19NO4) (K6) was the alkaloid with the highest content. [0003] At present, there is no literature report on the determination method of K6 i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): G01N30/88
Inventor 张军储继红李长印居文政吴婷许美娟刘史佳
Owner JIANGSU PROVINCIAL HOSPITAL OF TCM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap